MedKoo Cat#: 534503 | Name: Nimodipine-M2

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Nimodipine-M2, also known as Nimodipine Metabolite 2, is a monohdroxy metabolite of Nimodipine.

Chemical Structure

Nimodipine-M2
CAS#663163-06-2

Theoretical Analysis

MedKoo Cat#: 534503

Name: Nimodipine-M2

CAS#: 663163-06-2

Chemical Formula: C21H26N2O8

Exact Mass: 434.1689

Molecular Weight: 434.45

Elemental Analysis: C, 58.06; H, 6.03; N, 6.45; O, 29.46

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Monohydroxy of nimodipine; Nimodipine (m2); Nimodipine Metabolite 2;
IUPAC/Chemical Name
3-Isopropyl 5-(2-methoxyethyl) 2-(hydroxymethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
InChi Key
WOJJKAJVNDPQNA-UHFFFAOYSA-N
InChi Code
InChI=1S/C21H26N2O8/c1-12(2)31-21(26)19-16(11-24)22-13(3)17(20(25)30-9-8-29-4)18(19)14-6-5-7-15(10-14)23(27)28/h5-7,10,12,18,22,24H,8-9,11H2,1-4H3
SMILES Code
O=C(C1=C(CO)NC(C)=C(C(OCCOC)=O)C1C2=CC=CC([N+]([O-])=O)=C2)OC(C)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 434.45 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Zhang J, Jia Q, Qi J, Zhang H, Wu Y, Shi X. Exploring in vivo metabolism and excretion of QO-58L using ultra-high-performance liquid chromatography coupled with tandem mass spectrometry. Eur J Pharm Sci. 2018 May 30;117:379-391. doi: 10.1016/j.ejps.2018.02.015. Epub 2018 Feb 13. PMID: 29452212. 2: Sotoudegan F, Amini M, Faizi M, Aboofazeli R. Development of an RP-HPLC-UV Method for Simultaneous Detection of Nimodipine and its Metabolite in Cerebrospinal Fluid of Rat. Iran J Pharm Res. 2017 Spring;16(2):471-477. PMID: 28979302; PMCID: PMC5603856. 3: Tang H, Tang Y, Li N, Shi Q, Guo J, Shang E, Duan JA. Neuroprotective effects of scutellarin and scutellarein on repeatedly cerebral ischemia-reperfusion in rats. Pharmacol Biochem Behav. 2014 Mar;118:51-9. doi: 10.1016/j.pbb.2014.01.003. Epub 2014 Jan 11. PMID: 24423938. 4: Hossain MM, Suzuki T, Richardson JR, Kobayashi H. Acute effects of pyrethroids on serotonin release in the striatum of awake rats: an in vivo microdialysis study. J Biochem Mol Toxicol. 2013 Feb;27(2):150-6. doi: 10.1002/jbt.21450. Epub 2012 Nov 6. PMID: 23132818; PMCID: PMC4003412. 5: Tu J, A J, Wang G, Wen H, Wang A, Di L, Cao B, Liu L. [Plasma metabonomics study of ischemic cerebral apoplexy rats treated with Tongsaimai pellets]. Zhongguo Zhong Yao Za Zhi. 2012 Apr;37(7):1028-33. Chinese. PMID: 22792811. 6: Del Viscovo A, Secondo A, Esposito A, Goglia F, Moreno M, Canzoniero LM. Intracellular and plasma membrane-initiated pathways involved in the [Ca2+]i elevations induced by iodothyronines (T3 and T2) in pituitary GH3 cells. Am J Physiol Endocrinol Metab. 2012 Jun 1;302(11):E1419-30. doi: 10.1152/ajpendo.00389.2011. Epub 2012 Mar 13. PMID: 22414808. 7: Ramoino P, Dini F, Bianchini P, Diaspro A, Guella G, Usai C. Biophysical effects of the natural product euplotin C on the Paramecium membrane. J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2009 Nov;195(11):1061-9. doi: 10.1007/s00359-009-0479-7. Epub 2009 Sep 24. PMID: 19777247. 8: Cui JG, Zhang X, Zhao YH, Chen C, Bazan N. Allodynia and hyperalgesia suppression by a novel analgesic in experimental neuropathic pain. Biochem Biophys Res Commun. 2006 Nov 17;350(2):358-63. doi: 10.1016/j.bbrc.2006.09.055. Epub 2006 Sep 22. Erratum in: Biochem Biophys Res Commun. 2007 Jul 10;359(1):187-8. PMID: 17010939. 9: Shideman CR, Hu S, Peterson PK, Thayer SA. CCL5 evokes calcium signals in microglia through a kinase-, phosphoinositide-, and nucleotide-dependent mechanism. J Neurosci Res. 2006 Jun;83(8):1471-84. doi: 10.1002/jnr.20839. PMID: 16547971. 10: Nassar AE. Online hydrogen-deuterium exchange and a tandem-quadrupole time- of-flight mass spectrometer coupled with liquid chromatography for metabolite identification in drug metabolism. J Chromatogr Sci. 2003 Sep;41(8):398-404. doi: 10.1093/chromsci/41.8.398. PMID: 14558931. 11: Woszczyk A, Deinsberger W, Böker DK. Nitric oxide metabolites in cisternal CSF correlate with cerebral vasospasm in patients with a subarachnoid haemorrhage. Acta Neurochir (Wien). 2003 Apr;145(4):257-63; discussion 263-4. doi: 10.1007/s00701-003-0004-7. PMID: 12748885. 12: Zhou Q, Yao TW, Zeng S. Chiral metabolism of propafenone in rat hepatic microsomes treated with two inducers. World J Gastroenterol. 2001 Dec;7(6):830-5. doi: 10.3748/wjg.v7.i6.830. PMID: 11854911; PMCID: PMC4695604. 13: Campbell CA, Barone FC, Benham CD, Hadingham SJ, Harries MH, Harling JD, Hills JM, Lewis VA, Mackay KB, Orlek BS, White RF, Parsons AA, Hunter AJ. Characterisation of SB-221420-A - a neuronal Ca(2+) and Na(+) channel antagonist in experimental models of stroke. Eur J Pharmacol. 2000 Aug 11;401(3):419-28. doi: 10.1016/s0014-2999(00)00470-2. PMID: 10936502. 14: Vainio PJ, Törnquist K, Tuominen RK. Cotinine and nicotine inhibit each other's calcium responses in bovine chromaffin cells. Toxicol Appl Pharmacol. 2000 Mar 1;163(2):183-7. doi: 10.1006/taap.1999.8863. PMID: 10698676. 15: Briede J, Daija D, Bisenieks E, Makarova N, Uldriķis J, Poikans J, Duburs G. Effects of some 1,4-dihydropyridine Ca antagonists on the blast transformation of rat spleen lymphocytes. Cell Biochem Funct. 1999 Jun;17(2):97-105. doi: 10.1002/(SICI)1099-0844(199906)17:2<97::AID-CBF814>3.0.CO;2-4. PMID: 10377955. 16: Maurer HH, Arlt JW. Screening procedure for detection of dihydropyridine calcium channel blocker metabolites in urine as part of a systematic toxicological analysis procedure for acidic compounds by gas chromatography-mass spectrometry after extractive methylation. J Anal Toxicol. 1999 Mar- Apr;23(2):73-80. doi: 10.1093/jat/23.2.73. PMID: 10192408. 17: Zharkovsky A, Katajamäki J, Seppälä T, Ahtee L. Morphine-induced analgesia in rats withdrawn from concurrent nimodipine and morphine treatment. Pain. 1999 Feb;79(2-3):217-22. doi: 10.1016/s0304-3959(98)00176-6. PMID: 10068167. 18: Aymard G, Cayre-Castel M, Fernandez C, Lacomblez L, Diquet B. High- performance liquid chromatography with ultraviolet and fluorimetric detection for the simultaneous determination of tacrine, nimodipine, and their respective metabolites in the plasma of patients with Alzheimer disease. Ther Drug Monit. 1998 Aug;20(4):422-9. doi: 10.1097/00007691-199808000-00012. PMID: 9712468. 19: Fuhr U, Maier-Brüggemann A, Blume H, Mück W, Unger S, Kuhlmann J, Huschka C, Zaigler M, Rietbrock S, Staib AH. Grapefruit juice increases oral nimodipine bioavailability. Int J Clin Pharmacol Ther. 1998 Mar;36(3):126-32. PMID: 9562227. 20: Sautter J, Kupsch A, Earl CD, Oertel WH. Degeneration of pre-labelled nigral neurons induced by intrastriatal 6-hydroxydopamine in the rat: behavioural and biochemical changes and pretreatment with the calcium-entry blocker nimodipine. Exp Brain Res. 1997 Oct;117(1):111-9. doi: 10.1007/s002210050204. PMID: 9386009.